Mark Steven Pasternack, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningococcal Infections | 1 | 2007 | 77 | 0.290 |
Why?
|
| Neisseria meningitidis | 1 | 2007 | 109 | 0.290 |
Why?
|
| Infectious Mononucleosis | 1 | 2007 | 131 | 0.290 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2021 | 221 | 0.240 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2000 | 1820 | 0.230 |
Why?
|
| Arthritis, Infectious | 1 | 2007 | 367 | 0.220 |
Why?
|
| Campylobacter Infections | 1 | 2002 | 32 | 0.220 |
Why?
|
| Blood Bactericidal Activity | 1 | 1999 | 126 | 0.180 |
Why?
|
| Dysgammaglobulinemia | 1 | 2019 | 21 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2000 | 380 | 0.170 |
Why?
|
| Haptoglobins | 1 | 1999 | 165 | 0.160 |
Why?
|
| Granulocytes | 1 | 1999 | 546 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1999 | 675 | 0.140 |
Why?
|
| Whooping Cough | 1 | 1997 | 82 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1081 | 0.130 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 992 | 0.130 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 119 | 0.130 |
Why?
|
| Burns | 6 | 2012 | 1809 | 0.120 |
Why?
|
| Neonatal Screening | 3 | 2021 | 591 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2000 | 1351 | 0.120 |
Why?
|
| Phagocytosis | 1 | 1999 | 1538 | 0.120 |
Why?
|
| Pancreas | 1 | 2000 | 1684 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 2000 | 1073 | 0.110 |
Why?
|
| Immunization | 1 | 1997 | 1255 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 2003 | 2024 | 0.100 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1998 | 1368 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2016 | 402 | 0.100 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1990 | 28 | 0.100 |
Why?
|
| Minocycline | 1 | 2012 | 163 | 0.100 |
Why?
|
| Paramyxoviridae Infections | 1 | 1990 | 55 | 0.090 |
Why?
|
| Rifampin | 1 | 2012 | 315 | 0.090 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 1442 | 0.090 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 252 | 0.090 |
Why?
|
| Immunity, Cellular | 2 | 1992 | 1606 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2012 | 241 | 0.080 |
Why?
|
| Neutrophils | 1 | 2020 | 3711 | 0.080 |
Why?
|
| Streptococcal Infections | 2 | 2003 | 637 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2012 | 514 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 2 | 1990 | 817 | 0.070 |
Why?
|
| Serotyping | 1 | 2007 | 338 | 0.070 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 95 | 0.070 |
Why?
|
| Cell Death | 1 | 1992 | 1695 | 0.070 |
Why?
|
| Sarcoidosis | 1 | 2012 | 503 | 0.070 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 251 | 0.070 |
Why?
|
| Cytokines | 2 | 2020 | 7317 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 578 | 0.060 |
Why?
|
| Streptococcus milleri Group | 1 | 2003 | 6 | 0.060 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2003 | 14 | 0.060 |
Why?
|
| Burn Units | 2 | 2012 | 136 | 0.060 |
Why?
|
| Gonorrhea | 1 | 2007 | 335 | 0.060 |
Why?
|
| Arthralgia | 1 | 2007 | 456 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5425 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 2002 | 39 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 4 | 2016 | 7153 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3462 | 0.050 |
Why?
|
| Proteome | 1 | 2012 | 1790 | 0.050 |
Why?
|
| HL-60 Cells | 2 | 2000 | 365 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 1991 | 2440 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 1991 | 1899 | 0.050 |
Why?
|
| Wound Infection | 2 | 1994 | 240 | 0.050 |
Why?
|
| Enteritis | 1 | 2002 | 160 | 0.050 |
Why?
|
| Hypotension | 1 | 2007 | 880 | 0.050 |
Why?
|
| Orbital Diseases | 1 | 2003 | 181 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6313 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2003 | 235 | 0.040 |
Why?
|
| Acyclovir | 1 | 2000 | 272 | 0.040 |
Why?
|
| Insulinoma | 1 | 2000 | 124 | 0.040 |
Why?
|
| Tubulin | 1 | 2003 | 695 | 0.040 |
Why?
|
| Fever | 1 | 2007 | 1612 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1999 | 222 | 0.040 |
Why?
|
| Abscess | 1 | 2003 | 607 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 289 | 0.040 |
Why?
|
| Granzymes | 3 | 2000 | 270 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2000 | 742 | 0.040 |
Why?
|
| Penicillins | 1 | 2001 | 378 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2002 | 795 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2000 | 834 | 0.040 |
Why?
|
| Mitosis | 1 | 2003 | 1208 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 7645 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1998 | 122 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 374 | 0.040 |
Why?
|
| Caspases | 2 | 2000 | 928 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2003 | 861 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 1076 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 209 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 2000 | 466 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13814 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2000 | 810 | 0.040 |
Why?
|
| Infant | 7 | 2021 | 35070 | 0.040 |
Why?
|
| Cross Infection | 2 | 1997 | 1413 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 1999 | 689 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 1991 | 5851 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 1997 | 184 | 0.030 |
Why?
|
| Trypsin | 2 | 2000 | 509 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12958 | 0.030 |
Why?
|
| Substrate Specificity | 3 | 2000 | 1802 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 638 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 18112 | 0.030 |
Why?
|
| Humans | 29 | 2021 | 742088 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2837 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2257 | 0.030 |
Why?
|
| Dogs | 1 | 2000 | 3910 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 610 | 0.030 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 1994 | 8 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 563 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1999 | 1458 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4322 | 0.030 |
Why?
|
| Research Report | 1 | 2017 | 355 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 2021 | 25575 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10163 | 0.030 |
Why?
|
| Flavobacterium | 1 | 1993 | 19 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1997 | 633 | 0.030 |
Why?
|
| Methicillin Resistance | 1 | 1994 | 198 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2000 | 2978 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8662 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2000 | 1172 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 1768 | 0.030 |
Why?
|
| Lipid A | 1 | 1993 | 67 | 0.030 |
Why?
|
| Blood-Borne Pathogens | 1 | 2012 | 52 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3420 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5892 | 0.030 |
Why?
|
| Adolescent | 8 | 2019 | 85649 | 0.030 |
Why?
|
| Biopsy | 2 | 2016 | 6756 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 4742 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1538 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2524 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2012 | 264 | 0.030 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1993 | 232 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2021 | 2041 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2019 | 785 | 0.020 |
Why?
|
| Child, Preschool | 6 | 2016 | 40955 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 29 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6608 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 319 | 0.020 |
Why?
|
| Histones | 1 | 2000 | 2597 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1991 | 682 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1991 | 179 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2019 | 77098 | 0.020 |
Why?
|
| Child | 7 | 2019 | 77478 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 5019 | 0.020 |
Why?
|
| Female | 11 | 2020 | 379592 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 1989 | 192 | 0.020 |
Why?
|
| Medicine | 1 | 2017 | 941 | 0.020 |
Why?
|
| Ganciclovir | 1 | 1989 | 259 | 0.020 |
Why?
|
| Age of Onset | 1 | 2016 | 3266 | 0.020 |
Why?
|
| Base Sequence | 1 | 2000 | 12797 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 1801 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 246 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1653 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 782 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 981 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1999 | 4214 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5753 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10943 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2295 | 0.020 |
Why?
|
| Population Surveillance | 1 | 1997 | 2616 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1449 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2900 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3418 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 1398 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1988 | 906 | 0.020 |
Why?
|
| Animals | 8 | 2002 | 168561 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 962 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1993 | 2211 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56350 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 971 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2012 | 1949 | 0.020 |
Why?
|
| Lymphokines | 1 | 1988 | 949 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 3528 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21719 | 0.020 |
Why?
|
| Demecolcine | 1 | 2003 | 18 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 8333 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2003 | 2505 | 0.010 |
Why?
|
| Program Development | 1 | 2010 | 1314 | 0.010 |
Why?
|
| Adult | 5 | 2012 | 213712 | 0.010 |
Why?
|
| Sphenoid Sinusitis | 1 | 2003 | 9 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1991 | 5180 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
| Ethmoid Sinusitis | 1 | 2003 | 25 | 0.010 |
Why?
|
| U937 Cells | 1 | 2003 | 268 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1988 | 1663 | 0.010 |
Why?
|
| Tubulin Modulators | 1 | 2003 | 110 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 5249 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2107 | 0.010 |
Why?
|
| DNA Damage | 1 | 1992 | 2423 | 0.010 |
Why?
|
| Male | 8 | 2019 | 349538 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1988 | 1274 | 0.010 |
Why?
|
| Exophthalmos | 1 | 2003 | 96 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6096 | 0.010 |
Why?
|
| DNA | 2 | 2010 | 7289 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18355 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7141 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1988 | 710 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2010 | 2485 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 9715 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 7901 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2217 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9144 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2000 | 130 | 0.010 |
Why?
|
| Perforin | 1 | 2000 | 168 | 0.010 |
Why?
|
| HIV-1 | 1 | 1998 | 6934 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 1683 | 0.010 |
Why?
|
| Complement Activation | 1 | 2002 | 452 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2019 | 40450 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1831 | 0.010 |
Why?
|
| Mice | 5 | 2002 | 81045 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 2000 | 214 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6587 | 0.010 |
Why?
|
| K562 Cells | 1 | 2000 | 632 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3679 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1160 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 83 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 1998 | 128 | 0.010 |
Why?
|
| Caspase 2 | 1 | 1997 | 27 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20086 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 62966 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2479 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1997 | 176 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2000 | 1013 | 0.010 |
Why?
|
| Drainage | 1 | 2003 | 1140 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 190 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1997 | 344 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 242 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8297 | 0.010 |
Why?
|
| Cell Line | 1 | 1991 | 15994 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 898 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2271 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2012 | 23320 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4564 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1988 | 2130 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 9274 | 0.010 |
Why?
|
| Caspase 3 | 1 | 1997 | 759 | 0.010 |
Why?
|
| Spiramycin | 1 | 1994 | 3 | 0.010 |
Why?
|
| Sulfadiazine | 1 | 1994 | 18 | 0.010 |
Why?
|
| United States | 1 | 2002 | 69693 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6115 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1988 | 4393 | 0.010 |
Why?
|
| Clone Cells | 1 | 1998 | 1692 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 331 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 39004 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 1994 | 98 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15056 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1989 | 4414 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 20928 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3847 | 0.010 |
Why?
|
| Heparin | 1 | 2000 | 1636 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1994 | 253 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7276 | 0.010 |
Why?
|
| Leucovorin | 1 | 1994 | 624 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1993 | 6382 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1997 | 1176 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1969 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19862 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1468 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2968 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1997 | 3701 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 1997 | 786 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1993 | 758 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8621 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1994 | 518 | 0.010 |
Why?
|
| Virus Replication | 1 | 1998 | 2531 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 13853 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3769 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1994 | 1538 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1989 | 424 | 0.010 |
Why?
|
| Chromatin | 1 | 2000 | 2917 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1994 | 683 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 847 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 57683 | 0.000 |
Why?
|
| Infection Control | 1 | 1994 | 962 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3843 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5519 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2566 | 0.000 |
Why?
|
| Rats | 1 | 2002 | 24265 | 0.000 |
Why?
|
| Pneumonia | 1 | 1997 | 2117 | 0.000 |
Why?
|
| Aged | 2 | 2012 | 162944 | 0.000 |
Why?
|
| Mitochondria | 1 | 1997 | 3520 | 0.000 |
Why?
|
| Middle Aged | 2 | 2012 | 213127 | 0.000 |
Why?
|
| Monocytes | 1 | 1993 | 2593 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9639 | 0.000 |
Why?
|
| Sepsis | 1 | 1997 | 2589 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 4554 | 0.000 |
Why?
|
| Boston | 1 | 1994 | 9305 | 0.000 |
Why?
|
| Prognosis | 1 | 2000 | 29010 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 35342 | 0.000 |
Why?
|
| Time Factors | 1 | 1997 | 40054 | 0.000 |
Why?
|
| HIV Infections | 1 | 1998 | 16678 | 0.000 |
Why?
|
| Risk Factors | 1 | 1997 | 72145 | 0.000 |
Why?
|